Please try another search
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 215.7 million compared to CNY 160.92 million a year ago. Net income was CNY 49.82 million compared to CNY 35.07 million a year ago. Basic earnings per share from continuing operations was CNY 0.46 compared to CNY 0.32 a year ago. Diluted earnings per share from continuing operations was CNY 0.46 compared to CNY 0.32 a year ago.
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Total Revenue | 215.7 | 303.64 | 289.94 | 262.94 |
Gross Profit | 147.09 | 184.77 | 198.39 | 176.4 |
Operating Income | 47.97 | 47.19 | 99.66 | 87.1 |
Net Income | 49.82 | 70.48 | 82.03 | 84.39 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Total Assets | 3834.69 | 3669.11 | 3406.1 | 3381.52 |
Total Liabilities | 1093.3 | 984.97 | 805.82 | 836.83 |
Total Equity | 2741.39 | 2684.14 | 2600.28 | 2544.69 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | -121.98 | 56.92 | 33.36 | 3.54 |
Cash From Investing Activities | -233.07 | -190.2 | -194.51 | -173.42 |
Cash From Financing Activities | 261.25 | 82.12 | -25.99 | -58.94 |
Net Change in Cash | -93.8 | -51.24 | -187.14 | -228.88 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review